FIELD: chemistry.
SUBSTANCE: disclosed is use of copolymers of N-vinyl pyrrolidone of general formula (I), where the monomer link M is a fragment of 2-methyl-5-vinyl tetrazole (MVT) or 2-methyl-5-vinyl pyridine (MVP) and content of the monomer links n is equal to 25-50 mol %, and viscosity-average molecular weight Mµ of the copolymer depends on the nature of M: if M is MVT, Mµ=30-50 kDa; if M is MVP, Mµ=15-28 kDa, as activators of production of interleukin-1-alpha and interleukin-1-beta and anticancer agents. 
.
EFFECT: wider range of biologically active compounds suitable for use as activators of production of interleukin-1 and anti-cancer agents.
3 cl, 4 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COPOLYMERS OF 2-METHYL-5-VINYL-PYRIDINE AND N-VINYL PYRROLIDONE, HAVING PHAGOCYTOSIS ACTIVATOR PROPERTIES | 2010 |
|
RU2430933C1 |
| COPOLYMER CONTAINING N-VINYL PYRROLIDONE, 2-METHYL-5-VINYL PYRIDINE AND 4-VINYL PYRIDINE LINKS | 2011 |
|
RU2459838C1 |
| N-VINYLPYRROLIDONE BASED COPOLYMERS | 2010 |
|
RU2415876C1 |
| N-VINYLPYRROLIDONE-BASED COPOLYMERS IN FORM OF PHARMACEUTICALLY ACCEPTABLE SALTS OF ACIDS | 2013 |
|
RU2533113C1 |
| USE OF N-VINYLPYRROLIDONE COPOLYMER AS AGENT POTENTIATING ANALGESIC EFFECT OF MORPHINE HYDROCHLORIDE | 2011 |
|
RU2471491C1 |
| COPOLYMERS OF 4-VINYLPYRIDINE OR 2-METHYL-5-VINYLPYRIDINE AND N-VINYLPYRROLIDONE WITH TERMINAL CYANOVALERIC ACID RESIDUE AND USE THEREOF TO TREAT PNEUMOCONIOSIS | 2014 |
|
RU2550820C1 |
| MEDICINAL AGENT BASED ON SYNTHETIC COPOLYMER OF VINYLPYRIDINE ROW FOR TREATING TISSUE HELMINTHIASIS | 2019 |
|
RU2727935C1 |
| INTERPOLYMER POLYELECTROLYTE COMPLEX AND A PROLONGED IMMUNOSTIMULATING AGENT ON ITS BASIS, FOR MEDICAL AND VETERINARY USE | 2017 |
|
RU2683947C1 |
| OPHTHALMIC PREPARATION PRESENTED IN FORM OF EYE DROPS AND CONTAINING BRANCHED POLYHEXAMETHYLENE GUANIDINES | 2012 |
|
RU2510264C1 |
| SOLID DOSAGE FORM OF TAURINE WITH IMPROVED PHARMACOLOGICAL PROPERTIES | 2012 |
|
RU2495663C1 |
